company background image
537291 logo

Nath Bio-Genes (India) BSE:537291 Stock Report

Last Price

₹180.05

Market Cap

₹3.4b

7D

-4.8%

1Y

-14.9%

Updated

08 Jan, 2025

Data

Company Financials

Nath Bio-Genes (India) Limited

BSE:537291 Stock Report

Market Cap: ₹3.4b

537291 Stock Overview

Engages in the production, processing, and marketing of hybrid and GM seeds in India and internationally. More details

537291 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance2/6
Financial Health4/6
Dividends2/6

My Notes

Capture your thoughts, links and company narrative

Nath Bio-Genes (India) Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Nath Bio-Genes (India)
Historical stock prices
Current Share Price₹180.05
52 Week High₹264.50
52 Week Low₹167.50
Beta1.36
1 Month Change-11.41%
3 Month Change-13.60%
1 Year Change-14.87%
3 Year Change-32.58%
5 Year Change-51.30%
Change since IPO278.65%

Recent News & Updates

Recent updates

Shareholder Returns

537291IN FoodIN Market
7D-4.8%1.3%-0.07%
1Y-14.9%-0.4%16.0%

Return vs Industry: 537291 underperformed the Indian Food industry which returned -0.4% over the past year.

Return vs Market: 537291 underperformed the Indian Market which returned 16% over the past year.

Price Volatility

Is 537291's price volatile compared to industry and market?
537291 volatility
537291 Average Weekly Movement4.0%
Food Industry Average Movement6.1%
Market Average Movement6.2%
10% most volatile stocks in IN Market9.0%
10% least volatile stocks in IN Market4.1%

Stable Share Price: 537291 has not had significant price volatility in the past 3 months compared to the Indian market.

Volatility Over Time: 537291's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1979423Satish Kagliwalnathbiogenes.com

Nath Bio-Genes (India) Limited engages in the production, processing, and marketing of hybrid and GM seeds in India and internationally. It operates in two segments, Agricultural Activities and Trading Activities. The company offers fiber and oil seeds, including cotton and mustard; seeds for field crops, such as bajra, corn, paddy, wheat, and jowar; fruit seeds; and seeds for vegetables comprising chilli, onion, okra, tomato, brinjal, bottle gourd, bitter gourd, sponge gourd, ridge gourd, cucumber, coriander, sweet pepper, green peas, pumpkin, tinda, cabbage, and French beans.

Nath Bio-Genes (India) Limited Fundamentals Summary

How do Nath Bio-Genes (India)'s earnings and revenue compare to its market cap?
537291 fundamental statistics
Market cap₹3.42b
Earnings (TTM)₹393.73m
Revenue (TTM)₹3.51b

8.7x

P/E Ratio

1.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
537291 income statement (TTM)
Revenue₹3.51b
Cost of Revenue₹923.16m
Gross Profit₹2.59b
Other Expenses₹2.19b
Earnings₹393.73m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)20.72
Gross Margin73.70%
Net Profit Margin11.22%
Debt/Equity Ratio19.9%

How did 537291 perform over the long term?

See historical performance and comparison

Dividends

1.1%

Current Dividend Yield

10%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/08 20:14
End of Day Share Price 2025/01/08 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Nath Bio-Genes (India) Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kameswari V. S. ChavaliFirstCall Research